AbbVie Inc (ABBV)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $521.50B
Last updated: Nov 17, 2026 at 11:05 AM ET
AbbVie Inc (ABBV) Competitors
The companies most similar to AbbVie are Amgen (AMGN), AstraZeneca (AZN) and Merck & Company (MRK). AbbVie trades at 23.0x earnings, against a median of 20.0x for the 9 of these companies with a P/E. By market cap, AbbVie ranks 3rd of the 13 companies on this page; Eli Lilly and Company (LLY) is the largest at $1.29T.
Peer Comparison
ABBV's ROIC of 16.4% is above the peer median of 13.2%, and its revenue growth of 10.3% is above the median of 6.8%. Its dividend yield is in line with the peer median.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| AbbVie (ABBV) | $521.50B | 23.0x | 7.9x | 15.7% | 16.4% | 10.3% | 2.35% |
| Amgen Inc (AMGN) | $251.89B | 19.9x | 6.4x | 24.1% | 17.0% | 8.5% | 2.18% |
| AstraZeneca PLC (AZN) | $286.07B | 22.5x | 4.6x | 17.7% | 14.9% | 6.7% | 1.16% |
| Merck & Company Inc (MRK) | $364.26B | 46.3x | 5.3x | 3.6% | 3.1% | 4.7% | 2.35% |
| Novartis AG ADR (NVS) | $303.12B | 18.7x | 5.4x | 17.5% | 13.5% | 4.7% | 2.98% |
| Johnson & Johnson (JNJ) | $687.89B | 26.6x | 6.9x | 16.2% | 12.8% | 5.9% | 1.90% |
| Gilead Sciences Inc (GILD) | $208.48B | N/A | 6.7x | -12.5% | -3.9% | 6.8% | 1.96% |
| Eli Lilly and Company (LLY) | $1.29T | 44.9x | 14.8x | 31.9% | 30.7% | 38.6% | 0.48% |
| Pfizer Inc (PFE) | $164.67B | 9.5x | 2.6x | 6.3% | 2.7% | -0.4% | 5.96% |
| Bristol-Myers Squibb Company (BMY) | $129.66B | 10.1x | 2.6x | 18.5% | 13.9% | 6.9% | 4.00% |
| Novo Nordisk A/S (NVO) | $183.52B | N/A | 3.6x | 33.9% | 34.1% | 5.6% | 4.32% |
| Sanofi ADR (SNY) | $116.15B | N/A | 2.0x | 8.2% | 7.6% | 15.7% | 5.01% |
| Abbott Laboratories (ABT) | $187.95B | 20.0x | 3.9x | 9.8% | 6.3% | 14.5% | 2.34% |
| Peer median | $230.18B | 20.0x | 5.0x | 16.9% | 13.2% | 6.8% | 2.35% |
Similar Companies
These are the 12 companies most similar to AbbVie, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Drug Manufacturers - General; the other one is in Medical Devices.
| Company | About | Peers |
|---|---|---|
| Amgen Inc (AMGN)Drug Manufacturers - General | Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. | AMGN competitors |
| AstraZeneca PLC (AZN)Drug Manufacturers - General | AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory... | AZN competitors |
| Merck & Company Inc (MRK)Drug Manufacturers - General | Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. | MRK competitors |
| Novartis AG ADR (NVS)Drug Manufacturers - General | Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland. | NVS competitors |
| Johnson & Johnson (JNJ)Drug Manufacturers - General | Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. | JNJ competitors |
| Gilead Sciences Inc (GILD)Drug Manufacturers - General | Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California... | GILD competitors |
| Eli Lilly and Company (LLY)Drug Manufacturers - General | Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. | LLY competitors |
| Pfizer Inc (PFE)Drug Manufacturers - General | Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. | PFE competitors |
| Bristol-Myers Squibb Company (BMY)Drug Manufacturers - General | Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. | BMY competitors |
| Novo Nordisk A/S (NVO)Drug Manufacturers - General | Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. | NVO competitors |
| Sanofi ADR (SNY)Drug Manufacturers - General | Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe... | SNY competitors |
| Abbott Laboratories (ABT)Medical Devices | Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. | ABT competitors |
Frequently Asked Questions About ABBV
Who are AbbVie's main competitors?
The companies most similar to AbbVie include Amgen (AMGN), AstraZeneca (AZN), Merck & Company (MRK), Novartis AG ADR (NVS) and Johnson & Johnson (JNJ), listed from the closest match.
Who is AbbVie's biggest competitor?
Eli Lilly and Company (LLY) is the largest of the similar companies at $1.29T; Amgen (AMGN) is the closest match by business profile, size, sector and industry.
How does ABBV stock compare with its competitors?
ABBV's P/E is 23.0x against a peer median of 20.0x; its P/S is 7.9x against a peer median of 5.0x; its net margin is 15.7% against a peer median of 16.9%.
Which of AbbVie's competitors pays a higher dividend?
AbbVie has a forward dividend yield of 2.35%. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY), Novartis AG ADR (NVS) and Merck & Company (MRK) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.
Is AbbVie bigger than its competitors?
No. AbbVie is 3rd by market cap among the 13 companies on this page; the largest is Eli Lilly and Company (LLY) at $1.29T.
ABBV pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts